Based on the murine model mimicking FGFR2 fusion (FF)-driven ICC pathogenesis, this study demonstrated that the FF oncogenic activity in ICC required the activation of a downstream effector called MEK. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.